Genomic research focuses on studying the map of the normal human genome.
Chronix s technology is based in part on the detours or reshuffled genes the human genome map may take when confronted with viruses or other toxic environmental exposures. In addition, Hemispherx will make available to Chronix its considerable CFS data bank to enable the alliance to isolate potentially unique human gene sequences particular to CFS, GWS and related chronic diseases. The criteria for partner selection is to focus on companies, whose products can potentially remove, control or eliminate reshuffled RNA genes. Additionally, Veterans Administration data indicate at least 1,300 veterans have died from cancer and that several thousand more have died from other diseases. Recent Congressional testimony suggested that a secret to GWS may lie in the reshuffled genes, the subject of a peer-reviewed scientific article by Chronix principals.